Flu Vaccine Market

1. The Global Flu Vaccine Market accounted for US$ 4572.3 million in 2020 and is estimated to be US$ 8179.4 million by 2030 and is anticipated to register a CAGR of 6.0%. Influenza virus is continuously circulating causing regional epidemics and outbreaks, leading to thousands of deaths. For instance, according to Centers for Disease Control and Prevention (CDC) more than 13 million flu cases are recorded so far in the time-frame of 2019-20. World Health Organization (WHO) recommended numerous licensed seasonal influenza vaccines. The rising demand for vaccine is anticipated to surge the global influenza vaccine market. The report "Global Flu Vaccine Market, By Type (Split Virus Vaccines, Subunit Vaccines, and Others), By Application (For Children and For Adults and Children over 3 years), and By Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) - Trends, Analysis and Forecast till 2030” Key Highlights: In 2020, Abbott launched a new inactivated quadrivalent vaccine for influenza, first of its kind sub-unit vaccine offering protection against this strains in India. Approved vaccine is for below 3 years. In August 2020, AstraZeneca increases its manufacturing effects to deliver more FluMIST by collaborating with top key players such as GlaxoSmithKline, Sanofi, Seqirus in efforts to increase the manufacturing of vaccine Analyst View: Increasing investment and the growing government funding have boosted research and development of pharmaceutical companies which drives the market. Growing demand for pediatric vaccine as highest market size is covered among the age group. Quadrivalent vaccines are in great demands as they protect from four strains of the influenza virus through a single vaccine which boost the market of flu vaccine. Browse 60 market data tables* and 35 figures* through 140 slides and in-depth TOC on “Global Flu Vaccine Market, By Type (Split Virus Vaccines, Subunit Vaccines, and Others), By Application (For Children and For Adults and Children over 3 years), and By Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) - Trends, Analysis and Forecast till 2030” To know the upcoming trends and insights prevalent in this market, click the link below: https://www.prophecymarketinsights.com/market_insight/Global-Flu-Vaccine-Market-By-2230 Key Market Insights from the report: The Global Flu Vaccine Market accounted for US$ 4572.3 million in 2020 and is estimated to be US$ 8179.4 million by 2030 and is anticipated to register a CAGR of 6.0%. The Global Flu Vaccine Market is segmented based on the type, application and region. By Type, the Global Flu Vaccine Market is segmented into Split Virus Vaccines, Subunit Vaccines, and Others By Application, the market is segmented in For Children and For Adults and Children over 3 years By region, the Global Flu Vaccine Market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. Competitive Landscape: The key players operating in the Global Flu Vaccine Market include CSL Itd, GSK LLc, Sanofi Pasteur, Mylan N.V., AstraZeneca PLC, Pfizer Inc., and Johnson & Johnson Company.